0000950170-23-050434.txt : 20230928
0000950170-23-050434.hdr.sgml : 20230928
20230928160504
ACCESSION NUMBER: 0000950170-23-050434
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230928
DATE AS OF CHANGE: 20230928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaMond Stephen J
CENTRAL INDEX KEY: 0001951073
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39951
FILM NUMBER: 231289496
MAIL ADDRESS:
STREET 1: 3350 W BAYSHORE ROAD
STREET 2: SUITE 100
CITY: PALO ALTO
STATE: CA
ZIP: 94303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Peak Bio, Inc.
CENTRAL INDEX KEY: 0001834645
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 852448157
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4900 HOPYARD ROAD, SUITE 100
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: (925) 463-4800
MAIL ADDRESS:
STREET 1: 4900 HOPYARD ROAD, SUITE 100
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: Ignyte Acquisition Corp.
DATE OF NAME CHANGE: 20201202
4/A
1
ownership.xml
4/A
X0508
4/A
2023-09-15
2023-09-19
0001834645
Peak Bio, Inc.
PKBO
0001951073
LaMond Stephen J
4900 HOPYARD ROAD SUITE 100
PLEASANTON
CA
94588
true
true
false
false
See Remarks
false
Common Stock
2023-09-15
4
P
false
11750
A
11750
D
Common Stock
2023-09-18
4
P
false
2500
A
14250
D
Dr. LaMond previously reported purchases of 26,000 shares of the Company's Common Stock on September 15, 2023 in error. Instead, on September 15, 2023, Dr. Stephen LaMond purchased a total of 11,750 shares of the Company's Common Stock at prices ranging from $0.27 per share to $0.43 per share.
On September 18, 2023, Dr. Stephen LaMond purchased a total of 2,500 shares of the Company's Common Stock at prices ranging from $0.23 per share to $0.29 per share.
Interim Chief Executive Officer
/s/ Dr. Stephen LaMond
2023-09-28